Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression | Zendy

Rodolphe Thiébaut | Zendy; C. Charpentier | Zendy; Florence Damond | Zendy; Audrey Taïeb | Zendy; Rodolphe Antoine | Zendy; Jacqueline Capeau | Zendy; Geneviève Chêne | Zendy; Gilles Collin | Zendy; Sophie Matheron | Zendy; Diane Descamps | Zendy; Françoise BrunVézinet | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression

Author(s) -

Rodolphe Thiébaut,

C. Charpentier,

Florence Damond,

Audrey Taïeb,

Rodolphe Antoine,

Jacqueline Capeau,

Geneviève Chêne,

Gilles Collin,

Sophie Matheron,

Diane Descamps,

Françoise BrunVézinet

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis708

Subject(s) - medicine , asymptomatic , quartile , proportional hazards model , cd14 , cohort , viral load , immunology , c reactive protein , gastroenterology , disease , confounding , inflammation , human immunodeficiency virus (hiv) , confidence interval , receptor

Human immunodeficiency virus type 2 (HIV-2) infection is characterized by a slower progression than HIV type 1. It is not known whether markers of inflammation such as high-sensitivity C-reactive protein (hsCRP), interleukin 6 (IL-6), and soluble CD14 (sCD14) may predict disease progression among HIV-2 patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research